Vitamin B6 and Sleep: The Cofactor Behind the Curtain

By the YU Sleep Reviews Research Editorial Team · Updated 2026-09-18

What it is

Pyridoxine, the coenzyme form of which (PLP) catalyzes the decarboxylation steps that turn 5-HTP into serotonin and serotonin's downstream path toward melatonin. It's a rate-enabler: the precursor (5-HTP) and the signal (melatonin) both sit in YU Sleep's formula, and B6 is the worker between them.

What the research says

Direct sleep trials are preliminary but evocative: B6 appears in combination-formula insomnia research with positive results, and a small study linked evening B6 to dream recall — a quirky marker consistent with serotonin-pathway activity. Observational work ties low B6 status to poorer sleep and mood measures. The NIH fact sheet positions B6 around metabolism and neurotransmitter synthesis rather than as a sleep treatment — accurately so.

Evidence strength: early

Biology certain, sleep-specific trials thin. Tier: early, supportive.

Inside YU Sleep

Disclosed at 0.5 mg — near the daily requirement (adults need ~1.3–1.7 mg/day from all sources). That's a cofactor-support dose, appropriate for the role: nobody needs megadose B6 to run a pathway, and megadoses carry neuropathy risk over time. The restraint here is correct formulation.

Practical read

B6's story is a food story too — poultry, fish, potatoes, bananas keep status replete. The formula's 0.5 mg tops up the pathway on nights dinner was thin. Nobody buys YU Sleep for the B6; the formula doesn't work as coherently without it.